Review Article| Volume 50, ISSUE 1, P219-227, March 2023

A Clinical Review of the Use of Common Psychiatric Medications in Pregnancy

Guidelines for Obstetrical Providers


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.


      Subscribe to Obstetrics and Gynecology Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Hanley G.E.
        • Mintzes B.
        Patterns of psychotropic medicine use in pregnancy in the United States from 2006 to 2011 among women with private insurance.
        BMC Pregnancy Childbirth. 2014; 14: 242
        • Kennedy S.H.
        • Lam R.W.
        • McIntyre R.S.
        • et al.
        Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments.
        Can J Psychiatry. 2016; 61: 540-560
        • Betcher H.K.
        • Wisner K.L.
        Psychotropic treatment during pregnancy: research synthesis and clinical care principles.
        J Womens Health (Larchmt). 2020; 29: 310-318
        • Walton G.D.
        • Ross L.E.
        • Stewart D.E.
        • et al.
        Decisional conflict among women considering antidepressant medication use in pregnancy.
        Arch Womens Ment Health. 2014; 17: 493-501
        • Jarde A.
        • Morais M.
        • Kingston D.
        • et al.
        Neonatal outcomes in women with untreated antenatal depression compared with women without depression: a systematic review and meta-analysis.
        JAMA Psychiatry. 2016; 73: 826-837
        • Grigoriadis S.
        • Graves L.
        • Peer M.
        • et al.
        Maternal anxiety during pregnancy and the association with adverse perinatal outcomes: systematic review and meta-analysis.
        J Clin Psychiatry. 2018; 79: 17r12011
        • Liu X.
        • Wang S.
        • Wang G.
        Prevalence and risk factors of postpartum depression in women: a systematic review and meta-analysis.
        J Clin Nurs. 2021;
        • Stein A.
        • Pearson R.M.
        • Goodman S.H.
        • et al.
        Effects of perinatal mental disorders on the fetus and child.
        Lancet. 2014; 384: 1800-1819
        • Wikman A.
        • Skalkidou A.
        • Wikstrom A.K.
        • et al.
        Factors associated with re-initiation of antidepressant treatment following discontinuation during pregnancy: a register-based cohort study.
        Arch Womens Ment Health. 2020; 23: 709-717
        • Bayrampour H.
        • Kapoor A.
        • Bunka M.
        • et al.
        The risk of relapse of depression during pregnancy after discontinuation of antidepressants: a systematic review and meta-analysis.
        J Clin Psychiatry. 2020; 81: 19r13134
        • National Institutes of Clinical Excellence (NICE)
        Antenatal and postnatal mental health: clinical management and service guidance (CG192). NICE, London2014
        • Uguz F.
        Neonatal and childhood outcomes in offspring of pregnant women using antidepressant medications: a critical review of current meta-analyses.
        J Clin Pharmacol. 2021; 61: 146-158
        • De Vries C.
        • Gadzhanova S.
        • Sykes M.J.
        • et al.
        A systematic review and meta-analysis considering the risk for congenital heart defects of antidepressant classes and individual antidepressants.
        Drug Saf. 2021; 44: 291-312
        • Masarwa R.
        • Bar-Oz B.
        • Gorelik E.
        • et al.
        Prenatal exposure to selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors and risk for persistent pulmonary hypertension of the newborn: a systematic review, meta-analysis, and network meta-analysis.
        Am J Obstet Gynecol. 2019; 220: 57 e51-e57 e13
        • Andrade C.
        Selective serotonin reuptake inhibitor use in pregnancy and risk of postpartum hemorrhage.
        J Clin Psychiatry. 2022; 83
        • Wang J.
        • Cosci F.
        Neonatal withdrawal syndrome following late in utero exposure to selective serotonin reuptake inhibitors: a systematic review and meta-analysis of observational studies.
        Psychother Psychosom. 2021; 90: 299-307
        • Chaudron L.H.
        • Schoenecker C.J.
        Bupropion and breastfeeding: a case of a possible infant seizure.
        J Clin Psychiatry. 2004; 65: 881-882
        • Stewart D.E.
        • Vigod S.
        Postpartum Depression.
        N Engl J Med. 2016; 375: 2177-2186
        • Xu D.
        • Cardell E.
        • Broadley S.A.
        • et al.
        Efficacy of face-to-face delivered cognitive behavioral therapy in improving health status of patients with insomnia: a meta-analysis.
        Front Psychiatry. 2021; 12: 798453
        • Bais B.
        • Munk-Olsen T.
        • Bergink V.
        • et al.
        Prescription patterns of benzodiazepine and benzodiazepine-related drugs in the peripartum period: A population-based study.
        Psychiatry Res. 2020; 288: 112993
        • Grigoriadis S.
        • Graves L.
        • Peer M.
        • et al.
        Benzodiazepine use during pregnancy alone or in combination with an antidepressant and congenital malformations: systematic review and meta-analysis.
        J Clin Psychiatry. 2019; 80: 18r12412
        • Grigoriadis S.
        • Graves L.
        • Peer M.
        • et al.
        Pregnancy and delivery outcomes following benzodiazepine exposure: a systematic review and meta-analysis.
        Can J Psychiatry. 2020; 65: 821-834
        • Wang X.
        • Zhang T.
        • Ekheden I.
        • et al.
        Prenatal exposure to benzodiazepines and Z-drugs in humans and risk of adverse neurodevelopmental outcomes in offspring: a systematic review.
        Neurosci Biobehav Rev. 2022; 137: 104647
        • Wesseloo R.
        • Kamperman A.M.
        • Munk-Olsen T.
        • et al.
        Risk of postpartum relapse in bipolar disorder and postpartum psychosis: a systematic review and meta-analysis.
        Am J Psychiatry. 2016; 173: 117-127
        • Poels E.M.P.
        • Bijma H.H.
        • Galbally M.
        • et al.
        Lithium during pregnancy and after delivery: a review.
        Int J Bipolar Disord. 2018; 6: 26
        • Patorno E.
        • Huybrechts K.F.
        • Bateman B.T.
        • et al.
        Lithium use in pregnancy and the risk of cardiac malformations.
        N Engl J Med. 2017; 376: 2245-2254
        • Munk-Olsen T.
        • Liu X.
        • Viktorin A.
        • et al.
        Maternal and infant outcomes associated with lithium use in pregnancy: an international collaborative meta-analysis of six cohort studies.
        Lancet Psychiatry. 2018; 5: 644-652
        • Galbally M.
        • Roberts M.
        • Buist A.
        • et al.
        Mood stabilizers in pregnancy: a systematic review.
        Aust N Z J Psychiatry. 2010; 44: 967-977
        • Haskey C.
        • Galbally M.
        Mood stabilizers in pregnancy and child developmental outcomes: a systematic review.
        Aust N Z J Psychiatry. 2017; 51: 1087-1097
        • Toh S.
        • Li Q.
        • Cheetham T.C.
        • et al.
        Prevalence and trends in the use of antipsychotic medications during pregnancy in the U.S., 2001-2007: a population-based study of 585,615 deliveries.
        Arch Womens Ment Health. 2013; 16: 149-157
        • Tosato S.
        • Albert U.
        • Tomassi S.
        • et al.
        A systematized review of atypical antipsychotics in pregnant women: balancing between risks of untreated illness and risks of drug-related adverse effects.
        J Clin Psychiatry. 2017; 78: e477-e489
        • Andrade C.
        Major congenital malformations associated with exposure to second-generation antipsychotic drugs during pregnancy.
        J Clin Psychiatry. 2021; 82: 21f14252
        • Wang Z.
        • Wong I.C.K.
        • Man K.K.C.
        • et al.
        The use of antipsychotic agents during pregnancy and the risk of gestational diabetes mellitus: a systematic review and meta-analysis.
        Psychol Med. 2021; 51: 1028-1037
        • Vigod S.N.
        • Gomes T.
        • Wilton A.S.
        • et al.
        Antipsychotic drug use in pregnancy: high dimensional, propensity matched, population based cohort study.
        BMJ. 2015; 350: h2298
        • Wang Z.
        • Man K.K.C.
        • Ma T.
        • et al.
        Association between antipsychotic use in pregnancy and the risk of gestational diabetes: Population-based cohort studies from the United Kingdom and Hong Kong and an updated meta-analysis.
        Schizophr Res. 2021; 229: 55-62
        • Wang Z.
        • Chan A.Y.L.
        • Coghill D.
        • et al.
        Association between prenatal exposure to antipsychotics and attention-deficit/hyperactivity disorder, autism spectrum disorder, preterm birth, and small for gestational age.
        JAMA Intern Med. 2021; 181: 1332-1340
        • Halfdanarson O.
        • Cohen J.M.
        • Karlstad O.
        • et al.
        Antipsychotic use in pregnancy and risk of attention/deficit-hyperactivity disorder and autism spectrum disorder: a Nordic cohort study.
        Evid Based Ment Health. 2022; 25: 54-62